DDN, a privately held provider of outsourced channel management and business services to the life science industry, has completed an additional 140,000 square feet of temperature-controlled space, bringing its total Memphis TN footprint to 500,000 square feet. The company also announced plans for further expansion of its cold chain storage capacity for controlled and non-controlled products.
Mark Wiesman, DDN president, said recent investments have been made in response to increasing demand for outsourced logistics and warehousing services from pharmaceutical, biotech, and medical device companies.
“In today’s slow-growth economy, life science manufacturers are taking a hard look at the best use of their resources,” he said. “They’re opting to outsource capital-intensive warehousing and distribution infrastructure in order to free up cash for investments that will produce greater economic value.”
Wiesman said DDN is positioned to provide these services. “Because we focus exclusively on this industry, we know where it’s heading,” he said. “We can make the right investments in infrastructure that will best support our clients’ strategies. For us, that means continuing to invest in best-in-breed cold chain and tracking capabilities as the drug pipeline continues to shift towards biologics.”
DDN’s Memphis and Ontario CA warehouses were recently approved for accreditation renewal by the National Association of Boards of Pharmacy (NABP) in its Verified-Accredited Wholesale Distributors (VAWD) program and received certification for Current Good Manufacturing Practices (CGMP) for quality systems ensuring compliance with Food and Drug Administration regulations.
A subsidiary of the 153-year-old Dohmen Company, DDN is headquartered in Menomonee Falls WI with distribution facilities in Memphis and Ontario. For more information, call 888-374-8873 or visit www.ddnnet.com.